Erythropoietin ameliorates neonatal hypoxia-ischemia-induced neurobehavioral deficits,neuroinflammation, and hippocampal injury in the juvenile rat

International Journal of Molecular Sciences

Volumn 17, Issue 3, 2016, Pages

  Lan, Kuo Mao ^a,b   Tien, Lu Tai ^b   Cai, Zhengwei ^c   Lin, Shuying ^c   Pang, Yi ^c   Tanaka, Sachiko ^d   Rhodes, Philip G ^c   Bhatt, Abhay J ^c   Savich, Renate D ^c   Fan, Lir Wan ^c  

^a Chi Mei Foundation Hospital   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

Erythropoietin; Hypoxia ischemia; Neurobehavioral performance; Neuronal death

Indexed keywords

CD11B ANTIGEN; ERYTHROPOIETIN; MYELIN BASIC PROTEIN; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR ASSESSMENT; BRAIN INJURY; CAROTID ARTERY LIGATION; COGNITIVE DEFECT; COGNITIVE FUNCTION TEST; CONTROLLED STUDY; EXPLORATORY BEHAVIOR TEST; FEMALE; HIND LIMB SUSPENSION TEST; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MICROGLIA; MUSCLE STRENGTH; MYELINATION; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; OPEN FIELD TEST; PASSIVE AVOIDANCE TEST; RAT; REFLEX; STEREOLOGY; VIBRISSA; WHITE MATTER; ANIMAL; ASTROCYTE; COMPLICATION; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HIPPOCAMPUS; HUMAN; HYPOXIA-ISCHEMIA, BRAIN; METABOLISM; MOTOR DISORDERS; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ASTROCYTES; ERYTHROPOIETIN; HIPPOCAMPUS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; LOCOMOTION; MOTOR DISORDERS; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84959221489     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17030289     Document Type: Article

References (53)

1. Volpe, J.J. Brain injury in premature infants: A complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009, 8, 110–124. [CrossRef]
2. Volpe, J.J. Cerebral white matter injury of the premature infant-more common than you think. Pediatrics 2003, 112, 176–180. [CrossRef] [PubMed]
3. Cai, Z.; Lin, S.; Rhodes, P.G. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia. Eur. J. Pharmacol. 2002, 437, 139–145. [CrossRef]
4. Back, S.A.; Miller, S.P. Brain injury in premature neonates: A primary cerebral dysmaturation disorder? Ann. Neurol. 2014, 75, 469–486. [CrossRef] [PubMed]
5. Elitt, C.M.; Rosenberg, P.A. The challenge of understanding cerebral white matter injury in the premature infant. Neuroscience 2014, 276, 216–238. [CrossRef] [PubMed]
6. Fauchere, J.C.; Koller, B.M.; Tschopp, A.; Dame, C.; Ruegger, C.; Bucher, H.U.; Zeilinger, G.; Pasquier, S.; Bührer, C.; Glanzmann, R.; et, al. Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants. J. Pediatr. 2015, 167, 52–57. [CrossRef] [PubMed]
7. Juul, S.E. Erythropoietin as a neonatal neuronprotectant: Basic and clinical studies. Hematol. Meet. Rep. 2006, 2, 108–112.
8. Juul, S.E.; Ferriero, D.M. Pharmacologic neuroprotective strategies in neonatal brain injury. Clin. Perinatol. 2014, 41, 119–131. [CrossRef] [PubMed]
9. Messier, A.M.; Ohls, R.K. Neuroprotective effects of erythropoiesis-stimulating agents in term and preterm neonates. Curr. Opin. Pediatr. 2014, 26, 139–145. [CrossRef] [PubMed]
10. Rangarajan, V.; Juul, S.E. Erythropoietin: Emerging role of erythropoietin in neonatal neuroprotection. Pediatr. Neurol. 2014, 51, 481–488. [CrossRef] [PubMed]
11. Demers, E.J.; Mcpherson, R.J.; Juul, S.E. Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr. Res. 2005, 58, 297–301. [CrossRef] [PubMed]
12. Fan, X.; van Bel, F.; van der Kooij, M.A.; Heijnen, C.J.; Groenendaal, F. Hypothermia and erythropoietin for neuroprotection after neonatal brain damage. Pediatr. Res. 2013, 73, 18–23. [CrossRef] [PubMed]
13. Fan, X.; Heijnen, C.J.; van der Kooij, M.A.; Groenendaal, F.; van Bel, F. Beneficial effect of erythropoietin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice. Pediatr. Res. 2011, 69, 56–61. [CrossRef] [PubMed]
14. Gonzalez, F.F.; Abel, R.; Almli, C.R.; Mu, D.; Wendland, M.; Ferriero, D.M. Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev. Neurosci. 2009, 31, 403–411. [CrossRef] [PubMed]
15. Iwai, M.; Cao, G.; Yin, W.; Stetler, R.A.; Liu, J.; Chen, J. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke 2007, 38, 2795–2803. [CrossRef] [PubMed]
16. Kellert, B.A.; McPherson, R.J.; Juul, S.E. A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats. Pediatr. Res. 2007, 61, 451–455. [CrossRef] [PubMed]
17. Gluckman, P.D.; Wyatt, J.S.; Azzopardi, D.; Ballard, R.; Edwards, A.D.; Ferriero, D.M.; Polin, R.A.; Robertson, C.M.; Thoresen, M.; Whitelaw, A.; et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopthy: Multicentr randomized trial. Lancet 2005, 365, 663–670. [CrossRef]
18. Shankaran, S.; Laptook, A.R. Hypothermia as a treatment for birth asphyxia. Clin. Obstet. Gynecol. 2007, 50, 624–635. [CrossRef] [PubMed]
19. Back, S.A.; Han, B.H.; Luo, N.L.; Chricton, C.A.; Xanthoudakis, S.; Tam, J.; Arvin, K.L.; Holtzman, D.M. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J. Neurosci. 2002, 22, 455–463. [PubMed]
20. Back, S.A.; Luo, N.L.; Borensteinm, N.S.; Levine, J.M.; Volpe, J.J.; Kinney, H.C. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J. Neurosci. 2001, 21, 1302–1312. [PubMed]
21. Craig, A.; Luo, N.L.; Beardsley, D.J.; Wingate-Pearse, N.; Walker, D.W.; Hohimer, A.R.; Back, S.A. Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation to human. Exp. Neurol. 2003, 181, 231–240. [CrossRef]
22. Wen, T.C.; Rogido, M.; Peng, H.; Genetta, T.; Moore, J.; Sola, A. Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats. Neuroscience 2006, 139, 803–811. [CrossRef] [PubMed]
23. Altman, J.; Sudarshan, K.; Das, G.D.; McCormick, N.; Barnes, D. The influence of nutrition on neural and behavioral development: III. Development of some motor, particularly locomotor patterns during infancy. Dev. Psychobiol. 1971, 4, 97–114. [CrossRef] [PubMed]
24. Hermans, R.H.; Hunter, D.E.; McGivern, R.F.; Cain, C.D.; Longo, L.D. Behavioral sequelae in young rats of acute intermittent antenatal hypoxia. Neurotoxicol. Teratol. 1992, 14, 119–129. [CrossRef]
25. Altman, J.; Sudarshan, K. Postnatal development of locomotion in the laboratory rat. Anim. Behav. 1975, 23, 896–920. [CrossRef]
26. El-Khodor, B.F.; Edgar, N.; Chen, A.; Winberg, M.L.; Joyce, C.; Brunner, D.; Suárez-Fariñas, M.; Heyes, M.P. Identification of a battery of tests for drug candidate evaluation in the SMNDD7 neonate model of spinal muscular atrophy. Exp. Neurol. 2008, 212, 29–43. [CrossRef] [PubMed]
27. Murtie, J.C.; Zhou, Y.X.; Le, T.Q.; Armstrong, R.C. In vivo analysis of oligodendrocyte lineage development in postnatal FGF2 null mice. Glia 2005, 49, 542–554. [CrossRef] [PubMed]
28. Fan, L.W.; Lin, S.; Pang, Y.; Lei, M.; Zhang, F.; Rhodes, P.G.; Cai, Z. Hypoxia-ischemia induced neurological dysfunction and brain injury in the neonatal rat. Behav. Brain Res. 2005, 165, 80–90. [CrossRef] [PubMed]
29. Fan, L.W.; Lin, S.; Pang, Y.; Rhodes, P.G.; Cai, Z. Minocycline attenuates hypoxia-ischemia-induced neurological dysfunction and brain injury in the juvenile rat. Eur. J. Neurosci 2006, 24, 341–350. [CrossRef] [PubMed]
30. Schmued, L.C.; Hopkins, K.J. Fluoro-Jade-B: A high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 2000, 874, 123–130. [CrossRef]
31. Haroutunian, V.; Katsel, P.; Roussos, P.; Davis, K.L.; Altshuler, L.L.; Bartzokis, G. Myelination, oligodendrocytes, and serious mental illness. Glia 2014, 62, 1856–1877. [CrossRef] [PubMed]
32. Weinstein, M.; Marom, R.; Berger, I.; Ben Bashat, D.; Gross-Tsur, V.; Ben-Sira, L.; Artzi, M.; Uliel, S.; Leitner, Y.; Geva, R. Neonatal neuropsychology: Emerging relations of neonatal sensory-motor responses to white matter integrity. Neuropsychologia 2014, 62, 209–219. [CrossRef] [PubMed]
33. Sugawa, M.; Sakurai, Y.; Ishikawa-Ieda, Y.; Suzuki, H.; Asou, H. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci. Res. 2002, 22, 391–403. [CrossRef]
34. Antoniou, K.; Papathanasiou, G.; Panagis, G.; Nomikos, G.G.; Hyphantis, T.; Papadopoulou-Daifoti, Z. Individual responses to novelty predict qualitative differences in d-amphetamine-induced open field but not reward-related behaviors in rats. Neuroscience 2004, 123, 613–623. [CrossRef] [PubMed]
35. Woodlee, M.T.; Asseo-garcia, A.M.; Zhao, X.; Liu, S.J.; Jones, T.A.; Schallert, T. Testing forelimb placing “across the midline” reveals distinct, lesion-dependent patterns of recovery in rats. Exp. Neurol. 2005, 191, 310–317. [CrossRef] [PubMed]
36. Bakos, J.; Duncko, R.; Makatsori, A.; Pirnik, Z.; Kiss, A.; Jezova, D. Prenatal immune challenge affects growth, behavior, and brain dopamine in offspring. Ann. N. Y. Acad. Sci. 2004, 1018, 281–287. [CrossRef] [PubMed]
37. Zhu, Y.; Liu, F.; Zou, X.; Torbey, M. Comparison of unbiased estimation of neuronal number in the rat hippocampus with different staining methods. J. Neurosci. Methods 2015, 254, 73–79. [CrossRef] [PubMed]
38. Kreutzberg, G.W. Microglia: A sensor for pathological events in the CNS. Trends Neurosci. 1996, 19, 312–318. [CrossRef]
39. Juul, S.E.; Beyer, R.P.; Bammler, T.K.; McPherson, R.J.; Wilkerson, J.; Farin, F.M. Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus. Pediatr. Res. 2009, 65, 485–492. [CrossRef] [PubMed]
40. Sun, Y.; Calvert, J.W.; Zhang, J.H. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 2005, 36, 1672–1678. [CrossRef] [PubMed]
41. Villa, P.; Bigini, P.; Mennini, T.; Agnello, D.; Laragione, T.; Cagnotto, A.; Viviani, B.; Marinovich, M.; Cerami, A.; Coleman, T.R; et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 2003, 198, 971–975. [CrossRef] [PubMed]
42. Martin, R.; Dombrowski, S.C. Prenatal central nervous system development. In Prenatal Exposures: Psychological and Educational Consequences for Children; Springer: New York, NY, USA, 2008; pp. 15–25.
43. Semple, B.D.; Blomgren, K.; Gimlin, K.; Ferriero, D.M.; Noble-Haeusslein, L.J. Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog. Neurobiol. 2013, 1–16. [CrossRef] [PubMed]
44. Salmeen, K.E.; Jelin, A.C.; Thiet, M.P. Perinatal neuroprotection. F1000Prime Rep. 2014, 6, 6. [CrossRef] [PubMed]
45. Chen, S.J.; Wang, Y.L.; Lo, W.T.; Wu, C.C.; Hsieh, C.W.; Huang, C.F.; Lan, Y.H.; Wang, C.C.; Chang, D.M.; Sytwu, H.K. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 2010, 162, 210–223. [CrossRef] [PubMed]
46. Wiessner, C.; Allegrini, P.R.; Ekatodramis, D.; Jewell, U.R.; Stallmach, T.; Gassmann, M. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J. Cereb. Blood Flow Metab. 2001, 21, 857–864. [CrossRef] [PubMed]
47. Chen, Z.Y.; Wang, L.; Asavaritkrai, P.; Noguchi, C.T. Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning. J. Neurosci. Res. 2010, 88, 3180–3188. [CrossRef] [PubMed]
48. Wang, L.; Di, L.; Noguchi, C.T. Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system. Int. J. Biol. Sci. 2014, 10, 921–939. [CrossRef] [PubMed]
49. Zeng, S.M.; Yankowitz, J.; Widness, J.A.; Strauss, R.G. Etiology of differences in hematocrit between males and females: Sequence-based polymorphisms in erythropoietin and its receptor. J. Gend. Specif. Med. 2001, 4, 35–40. [PubMed]
50. Cohen, S.S.; Stonestreet, B.S. Sex differences in behavioral outcome following neonatal hypoxia ischemia: Insights from a clinical meta-analysis and a rodent model of induced hypoxic ischemic injury. Exp. Neurol. 2014, 256, 70–73. [CrossRef] [PubMed]
51. Fan, L.W.; Tin, L.T.; Zheng, B.; Pang, Y.; Rhodes, P.G.; Cai, Z. Interleukin-1-induced brain injury and neurobehavioral dysfunctions in juvenile rats can be attenuated by-phenyl-n-tert-butyl-nitrone. Neuroscience 2010, 168, 240–252. [CrossRef] [PubMed]
52. Kaizaki, A.; Tien, L.T.; Pang, Y.; Cai, Z.; Tanaka, S.; Numazawa, S.; Bhatt, A.J.; Fan, L.W. Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide. J. Neuroinflamm. 2013, 45, 10–23.
53. Fan, L.W.; Pang, Y.; Lin, S.; Tin, L.T.; Ma, T.; Rhodes, P.G.; Cai, Z. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J. Neurosci. Res. 2005, 82, 71–82. [CrossRef] [PubMed]